Pediatric Cardiology
Acetyl-L-carnitine may exert cardiac neurotrophic action
Published in Cardiovascular Week, January 30th, 2006
A recent report from Italy notes, "There is a higher incidence of sudden death in patients with Rett syndrome than individuals in the general population. Previous studies have implicated cardiac dysautonomia and a long QT interval as causative factors."
"Because carnitine plays a critical role in cellular metabolism and may have beneficial effects on cardiac and nerve function," wrote F. Guideri and colleagues at University of Siena, "we investigated the effects of long-term treatment with acetyl-L-carnitine on heart rate variability and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2006-01-30)
More Articles from Cardiovascular Week
- Atherosclerosis
Fas ligand gene transfer increases vulnerability of atherosclerosis - Atherosclerosis
MCP-1 and eotaxin levels are not indicators of atherosclerosis or myocardial infarction - Coronary Artery Disease
Base serum levels of inflammatory markers may be influenced by endogenous sex hormones - Statins
IB ultrasound indicates fluvastatin improved arterial sclerosis - Acute Myocardial Infarction
Adjunctive intravenous adenosine improves microvascular reflow after primary coronary stenting - Adverse Events
Medication with beta-blocker help prevent ICD shocks - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
